News Tagged ‘New York

HRT ads built trust, but breast cancer diagnoses changed opinions

hrt pillsThe advertisements no longer blanket magazines or fill television screens, but the message cannot be deleted. Over the years, millions of women were told that estrogen loss during menopause could be dangerous to their health, contributing to problems such as osteoporosis, heart disease, colon cancer, Alzheimer’s disease, tooth loss and blindness. It could also cause uncomfortable symptoms such as hot flashes, vaginal dryness and mood swings. The ads said menopause was a nasty disease that could be eliminated by just taking a once-daily pill, a hormone replacement therapy () that would help women feel like women again.

Read the rest of this entry »

Two breast cancer survivors awarded $100 million in HRT lawsuits

judge gavel1 100x100The message was heard loud and clear – powerful drug companies that make billions from products they know pose a significant risk of life-threatening health consequences to the people who take them, owe their victims. Big time.

This week, Pfizer, which recently acquired Wyeth, the makers of the replacement therapies () Prempro and Premarin, were hit with more than $100 million in two punitive-damage awards from Philadelphia juries. The two plaintiffs, Connie Barton and Donna Kendall, claimed the drugs caused their .

Read the rest of this entry »

Wyeth paid ghostwriters to sway doctors to prescribe HRT

Drug maker Wyeth paid ghostwriters to write articles for medical journals that were favorable to the company’s hormone replacement therapy () Prempro , even after the drug was found to raise a woman’s risk for and other serious health concerns, according to newly unveiled court documents. Medical journals such as The American Journal of Obstetrics and Gynecology and The International Journal of Cardiology name doctors as authors of articles that typically involve heavily research topics and offer a judgment on how to treat a particular condition. It is believed that doctors are often swayed by those published opinions and may be influenced by them when prescribing medication to their patients.

Read the rest of this entry »

Study: HRT puts women at greater risk for ovarian cancer

ovary 100x100Use of hormone replacement therapy () among postmenopausal women has been linked to a sharply increased risk of ovarian cancer, according to a study conducted by a team of researchers in Denmark. The study included data from 900,000 Danish women ages 50 to 79 over eight years and found 140 extra cases of ovarian cancer – or a 38 percent greater risk of contracting the disease compared to women who did not use .

Read the rest of this entry »

Study finds Wyeth paid ghostwriters to promote Prempro

A federal study revealed that the pharmaceutical company Wyeth paid ghostwriters to write articles for medical journals that were favorable to the drug company’s hormone replacement therapy (HRT) Prempro, even after the drug was found to raise a woman’s risk for , according to the New York Times.

Read the rest of this entry »

Wyeth faces more lawsuits for promoting sales despite concerns

In the 1960s, a New York gynecologist wrote a book called “Feminine Forever,” in which he recommended estrogen for menopause, stating that women on the replacement drug “will be much more pleasant to live with and will not become dull and unattractive.”

Wyeth Pharmaceuticals caught wind of the book and its author’s claims that estrogen reduced a woman’s risk for both breast and genital cancers, and began distributing the book to physicians across the country. Soon after, sales of Wyeth’s drug Premarin took off, growing to more than 30 million prescriptions each year.

Read the rest of this entry »

ProjectAWARE answers questions about menopause

Every woman approaching menopause or currently suffering from the symptoms of menopause has questions. How bad will the symptoms be? What is the best way to manage the symptoms? Will the treatment make me sick? Am I the only one who feels this way? In order to find answers most women have to educate themselves, and that can be a monumental task.

Read the rest of this entry »

High court may bar claims for FDA-approved drugs

The U.S. Supreme Court will hear arguments today in the first of two cases this term that consumer advocates fear could shut courthouse doors to patients injured by FDA-approved drugs or medical devices.

Legal experts say the cases could also affect lawsuits already filed by tens of thousands of Americans challenging the safety of blockbuster drugs such as Celebrex and Prempro and a host of medical devices.

Read the rest of this entry »